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Editorial on the Research Topic
Inflammation in the CNS: Advancing the Field Using Intravital Imaging
Inflammation of the central nervous system (CNS) contributes to a diverse array of life-threatening 
and debilitating conditions. These include autoimmune conditions such as multiple sclerosis (MS), 
progressive degenerative conditions [Alzheimer’s disease (AD)], sterile inflammation as occurs in 
stroke/cerebral ischaemia, and inflammation stemming from parasitic, fungal, viral, and bacterial 
infections. Whilst recent developments have led to improved outcomes in some of these conditions, 
most notably MS (1), there remains concerns with these approaches (2). Furthermore, there is an 
increasing prevalence of AD and stroke among the ageing population in the developed world, whilst 
in sub-Saharan Africa, cerebral malaria remains a major cause of mortality. These factors mandate 
a greater understanding of the inflammatory mechanisms in the CNS associated with these condi-
tions. As is the case with all inflammation, inflammatory responses in the CNS involve immune cell 
entry/migration, complex interplay between resident and circulating immune cells, parenchymal 
cells, the cellular constituents of the CNS microvasculature, and alterations in immune cell function.
Intravital or in vivo imaging has been a critical tool for understanding the mechanisms of inflam-
mation throughout the body, including in the brain (3–5). Particularly, the advent of two-photon 
intravital microscopy (2P-IVM) has allowed researchers to directly examine the role of multiple 
immune cell populations in the initiation and regulation of inflammation within the CNS. 2P-IVM 
has become a critical tool not only for understanding the complex interplay between the cellular 
components of the immune system and how they act to provide protection against infection and 
injury but also how the dysregulation of these processes leads to disease.
Whilst application of intravital imaging to the CNS has been technically challenging, several 
issues have been systematically addressed over the years to facilitate generation of high-quality four 
dimensional (x,y,z,t) images. These advances have proved pivotal in understanding animal models 
of CNS inflammation such as EAE. Moreover, the combination of ongoing technical developments 
in imaging technologies, reporter mice, and novel fluorophores for detection of cellular signalling, in 
parallel with improved animal models of CNS disease, has meant that the understanding of inflam-
matory processes in this unique organ is better than ever before.
This Frontiers Research Topic brings together studies illustrating how imaging has advanced CNS 
inflammation and provides an overview of what parameters can be assessed using this approach. 
A key point that emerges from this collection is that intravital imaging has moved beyond simplistic 
descriptions of immune cell accumulation at inflamed sites—new approaches allow investigation 
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of the molecular activities of these cells in situ in the CNS, in an 
ongoing inflammatory response, in unprecedented detail.
Activated T  cells migrating in non-lymphoid organs play 
important homeostatic and pathological roles, including in the 
CNS. Gaylo et  al. discuss the mechanisms that control T  cell 
interstitial migration, emphasising that inflammation can cause 
changes in the composition of the extracellular milieu in which 
T cells navigate. They describe how one of the challenges of using 
imaging to assess T cell migration in the brain is the difference 
in the composition of the stromal and parenchymal CNS compo-
nents relative to other peripheral tissues.
Lovelace et  al. examine evidence linking dysregulation of 
the kynurenine pathway of tryptophan metabolism and the 
pathogenesis of MS, highlighting the role of mononuclear phago-
cytes in generation of neurotoxic metabolites via this pathway. 
Investigation of this pathway in CNS inflammation has involved 
a diverse range of imaging approaches as described in this article, 
including assessment of the blood–retinal barrier in the eye, MRI 
for non-invasive assessment of the blood–brain barrier, 2P-IVM 
for examination of T cell infiltration in EAE, and correlative scan-
ning electron microscopy for assessment of cell–cell interactions 
in the brain.
Maysinger and Zhang define some of the emerging questions 
on the immunomodulatory effects of alimentary components, 
gut microbiota, and nanomaterials on microglial function and 
activation and discuss the use of bioluminescence-based plat-
forms for these analyses.
Pietronigro et al. examine innovative 2P-IVM-based approaches 
for visualisation of the progression of amyloid beta deposition 
and alterations in microglial behaviour in a mouse model of AD. 
This approach has revealed previously unrecognised actions of 
neutrophils in amyloid plaques in the brain.
Radbruch et al. present two studies applying advanced in vivo 
fluorescence lifetime imaging to examine the brain in EAE 
(Radbruch et  al.), and ageing and amyloid-related pathology 
(Radbruch et  al.). These studies use markers to differentiate 
between myeloid cells and astrocytes. Importantly, the authors 
illustrate the capacity of contemporary imaging approaches to 
move beyond simply describing cell behaviour into understand-
ing intracellular biochemistry and signalling of specific cell 
types in inflamed tissues, focussing on NAD(P)H oxidase (Nox) 
activity and Ca2+ signalling. In a separate article focussing on the 
remission phase of EAE, Radbruch et al. show that Nox activity 
remains elevated specifically in microglia. In contrast, under 
conditions of amyloid deposition, Nox activity is predominantly 
elevated in astrocytes (Radbruch et al.).
Fungal pathogens are an important cause of CNS pathology, 
particularly in immunocompromised individuals, although the 
mechanisms of fungal invasion of the brain are poorly under-
stood. Shi and Mody describe the use of confocal intravital 
microscopy to investigate the dynamic interactions undergone 
by Cryptococcus neoformans in the CNS microvasculature, and 
the unusual nature of the neutrophil response to this infection.
Finally, Sonar and Lal provide an overview of the role of 
TNFSF receptor–ligand interactions in driving the pathogenesis 
of neuroinflammation and autoimmune disease in the CNS.
In summary, we anticipate that the collection of articles in this 
Frontiers Research Topic will provide researchers with a useful 
resource for understanding how imaging can be used to inves-
tigate the dynamics of CNS inflammation in its various forms.
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